GENE ONLINE|News &
Opinion
Blog

2025-04-10| Neuro

Uncovering the Mysteries of Parkinson’s Disease and the Hidden Factors Shaping Its Progression

by Denisse Sandoval
Share To
April 11 marks World Parkinson’s Day, raising global awareness and supporting research efforts for Parkinson’s disease.

Today, April 11, marks Parkinson’s Awareness Day, an occasion aimed at increasing global understanding of Parkinson’s disease and highlighting the ongoing need for research and support. Parkinson’s disease is a chronic and progressive neurological disorder that results from the gradual loss of brain cells responsible for producing dopamine, a chemical critical for controlling movement. As dopamine levels decline, individuals experience increasing difficulties with motor functions.

Currently, the disease affects about 1 million people in the United States and approximately 10 million worldwide. Common symptoms include tremors, muscle stiffness, slowed movements, and impaired balance or coordination. These symptoms typically worsen over time, making the condition harder to manage. In the past decade, diagnoses in the U.S. have nearly doubled, and the numbers are expected to continue rising.

Genetic, Environmental, and Lifestyle Factors Contributing to Parkinson’s Disease Risk

Parkinson’s disease remains one of the most prevalent neurodegenerative disorders worldwide, yet many aspects of its cause, progression, and treatment continue to raise questions. Increased public awareness and access to expert insights are essential for improving understanding, supporting those affected, and advancing research.

Dr. Jeff Bronstein, professor of neurology and director of the Levine Family Center for Movement Disorders at UCLA, focuses his research on identifying the causes of Parkinson’s disease and advancing new treatment options. In recognition of World Parkinson’s Day, Dr. Bronstein addresses several frequently asked questions about the condition.

He started by noting that significant progress has been made in understanding the underlying causes of Parkinson’s disease. He explained that genetic factors, involving several specific genes, primarily cause about 5% of Parkinson’s cases.

Dr. Bronstein also pointed out that while some other genes may slightly influence risk, most contributing factors are environmental or lifestyle-related. These include exposure to pesticides, air pollution, and certain industrial solvents. Diet also plays a role, with Western-style eating patterns like high in red meat, fried foods, and sugar, linked to an increased risk. Additional factors such as head injuries and physical inactivity may also contribute. According to Dr. Bronstein, the cause of Parkinson’s often varies between individuals and typically results from a complex interaction between genetic predispositions and environmental influences.

Addressing Non-Motor Symptoms and the Need for Treatments to Slow Parkinson’s Disease Progression

Dr. Bronstein explained that current treatments effectively manage many Parkinson’s symptoms, but no medication has yet proven to slow the disease’s progression. Exercise remains the only intervention consistently shown to delay the worsening of symptoms, though several potential disease-modifying therapies are currently under investigation.

He also highlighted the importance of addressing non-motor symptoms, which can significantly impact quality of life. Parkinson’s reduces serotonin levels, which often leads to depression. Doctors commonly treat it with antidepressants to restore chemical balance. According to Dr. Bronstein, although existing therapies can manage most motor and non-motor symptoms, there is still an urgent need for treatments that can slow or halt disease progression.

Protein Intake Reduces Levodopa Absorption in Parkinson’s Treatment

Dr. Bronstein confirmed that levodopa remains the most essential medication for managing Parkinson’s disease. Dietary protein can affect the absorption of levodopa, a naturally occurring amino acid. He explained that consuming levodopa alongside a high-protein meal may reduce its effectiveness, since proteins compete for absorption in the digestive system. To address this, doctors typically advise patients to continue eating protein but take their medication about an hour before meals for optimal results.

He also pointed to growing evidence that diet may influence both the risk and progression of Parkinson’s. Research suggests that following a Mediterranean diet, rich in vegetables, fruits, whole grains, and healthy fats like olive oil, may help reduce the likelihood of developing the disease and slow its progression. Researchers have observed similar benefits with vegetarian diets. Dr. Bronstein noted that such eating patterns not only support Parkinson’s management but also contribute to overall health.

Dr. Bronstein acknowledged that some individuals with Parkinson’s disease experience mild memory issues or difficulty multitasking, similar to normal aging. However, he emphasized that these cognitive challenges typically do not escalate to the level of dementia in most cases. He also pointed out that Parkinson’s increases the risk of developing dementia, making it crucial for patients to remain both physically and mentally active to help reduce this risk.

He noted that staying physically and mentally engaged is beneficial not only for those with Parkinson’s but also for the general population, as it helps lower dementia risk. Maintaining a balanced diet, regular exercise, social interaction, and good sleep are key factors for anyone seeking to improve their quality of life as they age.

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Study Links Sleep Apnea to Higher Parkinson’s Risk, CPAP May Reduce Threat
2025-04-01
UCLA Study Reveals Mice Display Paramedic-Like Care to Unresponsive Peers
2025-02-25
R&D
The Latest in Alzheimer’s Research: Restoring Cognitive Function with Nanotech, Gene Therapy, and Enhanced Brain Gamma Oscillations
2024-08-16
LATEST
The Latest Talk in Cancer Immunotherapy: A Brief Overview of Developments & Current Players in the Exosome Space
2025-04-23
Unlocking the Gut Code: Japan’s Pharmaceutical Sector Explores the Future of Microbiome Therapeutics
2025-04-23
Advancing Pharmaceutical Regulatory Cooperation in Asia: The Vision and Challenges of GMP Inspection Reliance
2025-04-23
The Digital Revolution of Drug Labelling: FHIR and the Global Blueprint for e-Labelling
2025-04-23
Cross-Border Trust and Transparency: The New Landscape of Bridging the Regulatory Review in the Asia-Pacific
2025-04-23
From Cancer to Cosmetics, Physiological to Pathological – The Field of Exosomes Full of Endless Opportunities
2025-04-22
Sumitomo Pharma’s Comeback Story: Reinventing a Century-Old Giant in a Post-Patent Era
2025-04-22
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
Scroll to Top